🔥Very Popular

Tirzepatide

Also known as: Mounjaro, Zepbound, LY3298176

Weight LossHealthPerformance
FDA Approved

Primary recreational use: Weight loss and body composition improvement

What is Tirzepatide?

Tirzepatide is a dual-action peptide agonist targeting both the GIP and GLP-1 receptors. Originally developed for type 2 diabetes, it is FDA-approved for diabetes and chronic weight management. The peptide effectively mimics incretin hormones, aiding in blood sugar regulation and appetite suppression, with notable benefits in weight reduction. Despite its therapeutic potential, users should be aware of risks such as gastrointestinal discomfort and thyroid-related contraindications.

Primary Benefits

Promotes significant weight loss. Enhances glucose regulation. Reduces cardiovascular risk.

How It Works

Tirzepatide binds to both GLP-1 and GIP receptors, triggering pathways that enhance insulin secretion, reduce glucagon, and slow gastric emptying. This dual receptor activation synergistically suppresses appetite and improves metabolic regulation, contributing to its effects on weight and glucose levels.

Safety Tips

Precautions reported in community discussions and literature. This is not a complete list.

  • 1.DON'T use if you have a history of medullary thyroid cancer (MTC) or MEN 2.
  • 2.DON'T administer via routes other than subcutaneous injection.
  • 3.DON'T exceed recommended doses without medical supervision.
  • 4.DON'T shake the reconstituted solution vigorously as this damages the protein.
  • 5.NEVER share needles or vials to avoid infection risks.
  • 6.AVOID using during pregnancy unless benefits outweigh risks.
  • 7.DON'T use if you are dehydrated or susceptible to kidney issues.

Who Should NOT Use

  • Personal or family history of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2
  • Known hypersensitivity

Use Contexts

Different purposes have different protocols, dosing, and considerations

✓Approved Medical

Type 2 Diabetes

strong evidence

FDA-approved for controlling blood sugar levels in adults with type 2 diabetes. It enhances insulin secretion and improves glycemic control.

Evidence: Multiple RCTs demonstrate significant HbA1c reduction and metabolic benefits.

The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.

Reported Range
2.5-15 mg
Reported Frequency
once weekly
Reported Cycle
12-24 weeks
Reported Route
Subcutaneous

Timing: Any time of day, consistent weekly schedule

Notes: Start at 2.5 mg and increase as per tolerance and therapeutic response.

Community-Reported Protocols

Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.

Reported GoalReported DoseReported FrequencyReported Route
Glycemic control5mg weeklyonce weeklySubcutaneous injection

Pharmacokinetics

Half-Life
5 days
Time to Peak
8-72 hours
Clearance
Urine and feces

Reported Side Effects

This is not a complete list. Other side effects may occur.

Common
Nauseavery common (>10%)
Diarrheacommon (1-10%)
Serious / Rare
  • Pancreatitis
  • Gallbladder problems
Injection-Specific Warnings
  • Hypersensitivity at injection site

Storage

Temperature
2-8°C
Reconstituted
Refrigerate, use within 28 days
Shelf Life
Refrigerated until expiration date
Light Sensitive
Yes - protect from light
✓Approved Medical

Chronic Weight Management

strong evidence

Used in conjunction with diet and exercise to encourage weight loss. It helps reduce body weight and maintain weight loss long-term.

Evidence: Strong evidence from Phase 3 trials showing 15-22% weight reduction in overweight individuals.

The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.

Reported Range
5-15 mg
Reported Frequency
once weekly
Reported Cycle
12-24 weeks
Reported Route
Subcutaneous

Timing: Once weekly, same day and time

Notes: Initiate with 2.5 mg, adjust per response.

Community-Reported Protocols

Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.

Reported GoalReported DoseReported FrequencyReported Route
Maximum weight loss15mg weeklyonce weeklySubcutaneous injection

Pharmacokinetics

Half-Life
5 days
Time to Peak
8-72 hours
Clearance
Urine and feces

Reported Side Effects

This is not a complete list. Other side effects may occur.

Common
Constipationcommon (1-10%)
Decreased appetitevery common (>10%)
Serious / Rare
  • Acute kidney injury
  • Boxed warning for thyroid tumors
Injection-Specific Warnings
  • Ensure proper hydration

Storage

Temperature
2-8°C
Reconstituted
Refrigerate, use within 28 days
Shelf Life
Refrigerated until expiration date
Light Sensitive
Yes - protect from light

Harm Reduction Information

Quality Concerns

  • Purity and source verification needed for off-label or non-prescribed use

Safety Tips

  • Use sterile technique for each injection to prevent infections.
  • Rotate injection sites to reduce tissue damage.
  • Start with lower doses to monitor tolerance.
  • Monitor kidney function in people prone to dehydration.
  • Avoid alcohol to reduce risk of dehydration and hypoglycemia.

Warning Signs to Stop

  • Severe abdominal pain indicating pancreatitis
  • Signs of thyroid tumors such as lumps in the neck
  • Uncontrolled vomiting or diarrhea

Seek Medical Help Immediately If

  • Sudden severe stomach pain
  • Difficulty breathing or swallowing
  • Signs of acute kidney injury such as decreased urine output

Frequently Asked Questions

Common questions about Tirzepatide

How long until I see effects?

Tirzepatide often leads to appetite reduction within 1-3 days, with weight loss beginning in 2-4 weeks and peak effects seen at 12-20 weeks.

What time of day should I take it?

Tirzepatide should be administered once weekly on the same day, at any time, for consistent blood levels.

How can I minimize side effects?

To minimize gastrointestinal side effects, start with the lowest dose of Tirzepatide and increase gradually under supervision.

Does tolerance develop?

There is no indication of developing tolerance to Tirzepatide's weight loss or glucose-regulating effects.

How should I store it?

Store Tirzepatide in the refrigerator at 2-8°C and do not freeze. If stored at room temperature, use within 21 days.

Do I need to cycle it?

Tirzepatide is typically used for long-term management, but any changes should be supervised by a healthcare provider.

Can I combine it with other peptides?

Tirzepatide can be used alongside certain peptides like CJC-1295 and Ipamorelin, but avoid combination with other GLP-1 agonists like semaglutide.

What happens if I miss a dose?

If you miss a dose of Tirzepatide, administer it within 4 days, then resume your regular schedule.

Reported Combinations

Compounds reported to be used alongside Tirzepatide in community discussions

investigational

CJC-1295

Combined use can enhance overall metabolic benefits and fat loss when paired correctly.

recreational

Ipamorelin

May support additional muscle preservation during weight loss.

approved medical

Metformin

Provides complementary mechanisms to improve glycemic control and insulin sensitivity.

Reported Interactions

Interactions reported in literature and community discussions.

Semaglutidemajor

Avoid combination due to overlapping mechanisms and increased adverse effects.

Liraglutidemajor

Avoid combination due to enhanced GLP-1 effect.

Insulinmoderate

Monitor for hypoglycemia; a lower dose of insulin might be necessary.

Oral contraceptivesmoderate

May reduce efficacy; alternative contraception methods recommended.

Metforminminor

Safe for combination, enhances glucose control synergistically.

Reconstitution Calculator

mL
U100 insulin syringe01020304050607080901001mL

100 units = 1 mL

Safety Tips

  • Always consult a licensed medical professional for dosing and reconstitution instructions.
  • Always double check your units. Mixing up mg and mcg can be very dangerous.
  • Make sure to select your syringe type. U-100 and U-50 syringes have different units.
  • Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.

This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.

Explore More Research

Browse our database of peptide research information compiled from published literature and community sources.

Browse All PeptidesAbout Pepbase App

Citations

Last updated: October 2, 2023

Important Disclaimer

AI-Generated Content Notice

The information on this page has been compiled using artificial intelligence (AI) and large language model (LLM) technology from multiple sources including published literature, online communities, and public databases. This content may contain errors, inaccuracies, outdated information, or omissions. We make no guarantees regarding the accuracy, completeness, or reliability of any information presented. You are solely responsible for independently verifying any information before relying on it.

Not Medical Advice

Nothing on this website constitutes medical advice, diagnosis, or treatment recommendations. The information provided is for educational and harm-reduction purposes only. We do not provide individualized dosing guidance or treatment recommendations. Protocols and dosing information shown represent reports from community discussions and published literature—they are not endorsements or recommendations. Always consult with a licensed healthcare professional before making any health-related decisions.

No Endorsement of Use

Pepbase does not endorse, encourage, or recommend the use of any peptide or substance discussed on this website. Many compounds discussed are not approved for human use by the FDA or other regulatory agencies. Some substances may be illegal to possess, sell, or use in your jurisdiction. We do not facilitate or encourage the procurement, distribution, or use of controlled or prescription-only substances. Users are solely responsible for understanding and complying with all applicable laws in their jurisdiction.

Calculators and Tools

Any calculators, estimators, or tools provided on this website are for informational purposes only and produce estimates that may be inaccurate. Errors in calculations can result in serious harm. You are solely responsible for verifying all calculations independently. These tools do not account for individual factors that may affect dosing and should never be relied upon as a substitute for professional medical guidance.

Assumption of Risk

By using this website, you acknowledge that you understand the risks associated with using unregulated substances and that you assume full responsibility for your own health decisions. Pepbase, its creators, contributors, and affiliates disclaim all liability for any harm, injury, or damages arising from the use or misuse of information on this website. Use of any information on this site is entirely at your own risk.

If you are experiencing a medical emergency, call emergency services immediately. If you have questions about medications or supplements, consult a licensed pharmacist or physician.